Purple Biotech (PPBT) Non Operating Income (2014 - 2026)
Purple Biotech's (PPBT) quarterly Non Operating Income came in at -$2.2 million in Q1 2026, down 127.58% year-on-year from $7.8 million in Q1 2025, and down 1197.46% on a QoQ basis from $197000.0 in Q4 2025.
Purple Biotech (PPBT) Non Operating Income (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Non Operating Income data on file, last reported at -$2.2 million in Q1 2026.
- On a quarterly basis, Non Operating Income fell 127.58% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$2.2 million, a 46.44% increase from a year earlier, with the FY2025 full-year figure at $966000.0, down 74.07% from the prior year.
- Non Operating Income for Q1 2026 stood at -$2.2 million, down from $197000.0 in the prior quarter.
- Over the last five years, Non Operating Income for PPBT reached as high as $197000.0 in Q4 2025 and fell as low as -$2.2 million in Q1 2026.
- Historically, Non Operating Income has averaged -$591470.6 across 5 years, with a median of -$558000.0 in 2022.
- Across the five-year window, Non Operating Income soared 165.79% in 2023 and plunged 4272.0% in 2024, its largest moves.
- Year by year, Non Operating Income stood at -$558000.0 in 2022, then plunged by 152.33% to -$1.4 million in 2023, then surged by 57.32% to -$601000.0 in 2024, then jumped by 132.78% to $197000.0 in 2025, then plunged by 1197.46% to -$2.2 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$2.2 million in Q1 2026, $197000.0 in Q4 2025, and -$62000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | -2.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.16 Mn |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | -147,000.00 |
| Mar 31, 2025 | -950,000.00 |
| Dec 31, 2024 | -601,000.00 |
| Sep 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | -685,000.00 |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | -692,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | -219,000.00 |
| Dec 31, 2022 | -558,000.00 |
| Sep 30, 2022 | -232,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | -34,000.00 |
| Sep 30, 2021 | -47,000.00 |
| Jun 30, 2021 | 24,000.00 |